Hindustan Latex (HLL)has signed a memorandum of understanding (MoU) with Infrastructure Leasing and Financial Services (IL&FS) for developing an integrated medical devices and diagnostic manufacturing park (MediPark) at Chengalpet near Chennai, Tamil Nadu.
Gearing up to meet high standards of safety in blood transfusion, the Government has approved providing the four major metros with blood banks, which would also be centres of excellence for transfusion medicine.
[This article was published in the August 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Events Diary
TAKE Solutions announced recently that its worldwide business in regulatory document management and electronic submissions software arena is making quick inroads in the Indian market.
Belgaum-based Karnataka Legal Education (KLE) Society has bagged the INR 500 crore
[This article was published in the July 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
Business News
Kerala-based AyurVAID hospitals will be setting up six hospitals in the coming year in tier II cities and metros, with an equity investment of INR 4.5 crore, provided by a non-profit venture fund Acumen, US.
Pharmacy chain Medplus Health Services has opened its first five regional diagnostic centres already and has plans for 50 more by the end of the fiscal as it diversifies into the lucrative market for diagnostic services.
The hub and spoke model is increasingly being adopted to deliver high-end healthcare in smaller cities and one of the newest hospital chains to use this expansion route is the Global Hospital.
Indian hospitals are upping the ante on outsourcing. Instead of making heavy capital investments on expensive diagnostic equipment, costing INR 1.5 to INR 5 crore for MRI & CT scans, hospitals are opting for newer pay-per-use and outsourced models.
Computer Sciences Corp. has launched a new business unit dedicated to healthcare. CSC’s Healthcare Sector will focus on the information and service needs of healthcare providers, health plans, pharmaceutical and medical device manufacturers and allied industries globally.
Siemens Healthcare has announced its first molecular imaging biomarker production facility in Chennai, India. The new facility will enable the healthcare providers in and around Chennai to access the positron emission tomography-computed tomography (PET-CT) technology to diagnose patients with life-threatening diseases, such as cancer and cardiac and neurological ailments.
